A detailed history of Goldman Sachs Group Inc transactions in Generation Bio Co. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,188,203 shares of GBIO stock, worth $1.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,188,203
Previous 1,275,016 6.81%
Holding current value
$1.6 Million
Previous $3.6 Million 18.39%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.16 - $3.51 $187,516 - $304,713
-86,813 Reduced 6.81%
1,188,203 $2.93 Million
Q2 2024

Aug 13, 2024

BUY
$2.64 - $4.35 $86,922 - $143,223
32,925 Added 2.65%
1,275,016 $3.6 Million
Q1 2024

May 15, 2024

BUY
$1.73 - $4.07 $142,872 - $336,120
82,585 Added 7.12%
1,242,091 $5.06 Million
Q4 2023

Feb 13, 2024

BUY
$0.91 - $3.35 $426,823 - $1.57 Million
469,037 Added 67.93%
1,159,506 $1.91 Million
Q3 2023

May 14, 2024

SELL
$3.65 - $6.9 $1.71 Million - $3.24 Million
-469,037 Reduced 40.45%
690,469 $2.62 Million
Q3 2023

Nov 14, 2023

SELL
$3.65 - $6.9 $111,270 - $210,346
-30,485 Reduced 4.23%
690,469 $2.62 Million
Q2 2023

May 14, 2024

BUY
$3.5 - $5.67 $109,952 - $178,123
31,415 Added 4.56%
720,954 $3.97 Million
Q2 2023

Aug 14, 2023

BUY
$3.5 - $5.67 $109,952 - $178,123
31,415 Added 4.56%
720,954 $3.97 Million
Q1 2023

May 14, 2024

SELL
$3.61 - $7.01 $405,966 - $788,316
-112,456 Reduced 14.02%
689,539 $2.97 Million
Q1 2023

May 11, 2023

SELL
$3.61 - $7.01 $405,966 - $788,316
-112,456 Reduced 14.02%
689,539 $2.97 Million
Q4 2022

May 14, 2024

SELL
$3.66 - $6.77 $49,706 - $91,943
-13,581 Reduced 1.67%
801,995 $3.15 Million
Q4 2022

Feb 13, 2023

SELL
$3.66 - $6.77 $49,706 - $91,943
-13,581 Reduced 1.67%
801,995 $3.15 Million
Q3 2022

May 14, 2024

BUY
$4.68 - $8.34 $2.82 Million - $5.02 Million
601,954 Added 281.78%
815,576 $4.33 Million
Q3 2022

Nov 10, 2022

BUY
$4.68 - $8.34 $2.82 Million - $5.02 Million
601,954 Added 281.78%
815,576 $4.33 Million
Q2 2022

May 14, 2024

SELL
$4.87 - $9.41 $4.61 Million - $8.9 Million
-945,884 Reduced 81.58%
213,622 $1.4 Million
Q2 2022

Aug 15, 2022

BUY
$4.87 - $9.41 $41,170 - $79,552
8,454 Added 4.12%
213,622 $1.4 Million
Q1 2022

May 16, 2022

BUY
$4.16 - $7.76 $558,180 - $1.04 Million
134,178 Added 189.01%
205,168 $1.51 Million
Q4 2021

Feb 14, 2022

SELL
$5.99 - $24.97 $1.67 Million - $6.94 Million
-278,044 Reduced 79.66%
70,990 $503,000
Q3 2021

Nov 10, 2021

BUY
$20.0 - $27.43 $6.98 Million - $9.57 Million
349,034 New
349,034 $8.75 Million

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $79.7M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.